The US life science instrumentation market is estimated to grow at a CAGR of around 6.2% during the forecast period. The presence of major global players such as Illumina, Inc., Thermo Fisher Scientific, Inc., and others in the country coupled with growing R&D in the pharmaceutical Industry is act as the major factors responsible for the growth of the market. Moreover, the growing adoption of next-generation sequencing technologies in the research institutes and biotechnology companies further ample opportunity to the market in near future. Furthermore, the US life science instrumentation market is classified on the basis of technology and end-user.

Based on the technology, the market is further segregated into chromatography, spectroscopy, polymerase chain reaction (PCR), clinical chemistry analyzers, immunoassays, next-generation sequencing (NGS), flow cytometry, microscopy, and others (centrifuges, electrophoresis). The NGS segment is projected to have considerable growth during the forecast period owing to the increasing application in sequencing for cancer-based research. Based on the end-user, the US life science instrumentation market is further segmented into pharmaceutical & biotechnology companies, research institutes, and hospitals & laboratories. The pharmaceutical & biotechnology companies segment estimated to grow at a considerable CAGR during the forecast. 

Furthermore, the US life science instrumentation market is characterized by the presence of several market players that are catering to a wide range of customers across the globe. Some of the key players in the market include Agilent Technologies, Inc., Becton, Dickinson and Co., Bio-Rad Laboratories, Inc., Danaher Corp., Illumina, Inc., Thermo Fisher Scientific, Inc., and others. These players adopt various strategies to remain competitive in the market and gain a competitive advantage over other players operating in the market. Mergers and acquisitions, product launch, and partnerships and collaborations, and geographical expansion are some of the major activities adopted by the market players. 

Research Methodology

The market study of the US life science instrumentation market is incorporated by extensive primary and secondary research conducted by the research team.  Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research papers, and news blogs.
• Company websites and their product catalog.

The report is intended for life science instrumentation market players, the medical device industry, contract manufacturers, research institutes, distributors & traders, industry associates & experts, government organizations, regulatory bodies, and other market participants for the overall market and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. US life science instrumentation Market Research and Analysis by Technology
2. US life science instrumentation Market Research and Analysis by End-User

The Report Covers

• Comprehensive research methodology of the US life science instrumentation market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US life science instrumentation market.
• Insights about market determinants that are stimulating the US life science instrumentation market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.